3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
22 22 0 0 0 0 0 0 0999 V2000
-2.7714 0.7213 0.0016 S 0 0 0 0 0 0 0 0 0 0 0 0
0.2756 0.9600 0.0243 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.8861 1.3969 1.2809 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8732 1.4412 -1.2545 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4054 1.2808 1.1098 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2504 -1.5975 -0.0315 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0838 -1.2830 -0.0267 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4451 -0.5695 0.0593 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8193 -0.6257 -0.0289 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1924 0.0079 -0.0033 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1582 -0.5632 0.0178 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6007 -2.9988 0.0177 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0893 0.6485 0.1036 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4015 1.1810 -1.2703 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8051 -3.3002 1.0498 H 1 0 0 0 0 0 0 0 0 0 0 0
1.4918 -3.1988 -0.5861 H 1 0 0 0 0 0 0 0 0 0 0 0
-0.2100 -3.6249 -0.3701 H 1 0 0 0 0 0 0 0 0 0 0 0
-4.7653 -0.4881 0.3491 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.8152 -1.2008 -0.8811 H 0 0 0 0 0 0 0 0 0 0 0 0
3.2248 2.2601 -1.2897 H 1 0 0 0 0 0 0 0 0 0 0 0
4.4513 0.9785 -1.4986 H 1 0 0 0 0 0 0 0 0 0 0 0
2.7767 0.7159 -2.0380 H 1 0 0 0 0 0 0 0 0 0 0 0
1 3 2 0 0 0 0
1 4 2 0 0 0 0
1 9 1 0 0 0 0
1 10 1 0 0 0 0
2 10 1 0 0 0 0
2 11 1 0 0 0 0
5 13 2 0 0 0 0
6 7 1 0 0 0 0
6 11 1 0 0 0 0
6 12 1 0 0 0 0
7 10 2 0 0 0 0
8 11 2 0 0 0 0
8 13 1 0 0 0 0
9 18 1 0 0 0 0
9 19 1 0 0 0 0
12 15 1 0 0 0 0
12 16 1 0 0 0 0
12 17 1 0 0 0 0
13 14 1 0 0 0 0
14 20 1 0 0 0 0
14 21 1 0 0 0 0
14 22 1 0 0 0 0
M ISO 6 15 2 16 2 17 2 20 2 21 2 22 2
4. 国际命名与标识
4.1 IUPAC Name
2,2,2-trideuterio-N-[5-sulfamoyl-3-(trideuteriomethyl)-1,3,4-thiadiazol-2-ylidene]acetamide
4.2 InChl
InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)/i1D3,2D3
4.3 InChlKey
FLOSMHQXBMRNHR-WFGJKAKNSA-N
4.4 Canonical SMILES
CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C
4.5 lsomeric SMILES
[2H]C([2H])([2H])C(=O)N=C1N(N=C(S1)S(=O)(=O)N)C([2H])([2H])[2H]
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病